Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02834650 · ClinicalTrials.gov registry record · NA
Validating Cardiac MRI Biomarkers and Genotype-Phenotype Correlations for DMD
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 89
- Enrollment target
NCT02834650: Completed NA study, sponsored by Stanford University.
NCT02834650 is a NA study that has completed, run by Stanford University. The registered enrollment target is 89 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02834650, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 89 participants
- Enrollment target
Study Summary
This study will collect MRI from healthy volunteer boys and boys with Duchenne Muscular Dystrophy (DMD) to help researchers identify and validate cardiac MRI biomarkers to better understand the health of the heart and changes in heart health over time in boys with DMD. Currently, there is a lack of sufficiently well characterized cardiac MRI biomarkers that can serve as endpoints for detecting on-target and/or off-target cardiac effects during clinical drug trials for boys with DMD. Consequently, the first objective is to identify and characterize several cardiac MRI biomarkers for boys with DMD.
Interventions
- OTHER Heart Rate
- OTHER Cardiac MRI with contrast
- OTHER Cardiac MRI without contrast
- OTHER Blood Test
- OTHER Pulmonary Function Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2017-02-01 |
| Est. Completion | 2022-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02834650
The ClinicalTrials.gov registry entry for NCT02834650 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Heart Rate is the first listed.
NCT02834650 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02834650 about?
NCT02834650 is a clinical study titled "Validating Cardiac MRI Biomarkers and Genotype-Phenotype Correlations for DMD". This study will collect MRI from healthy volunteer boys and boys with Duchenne Muscular Dystrophy (DMD) to help researchers identify and validate cardiac MRI biomarkers to better understand the health of the heart and changes in heart health over time in boys with DMD. Currently, there is a lack of...
What is the current status of trial NCT02834650?
This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 2017-02-01. Estimated completion is 2022-03-30.
What interventions are being tested in trial NCT02834650?
The interventions under investigation include: Heart Rate (OTHER), Cardiac MRI with contrast (OTHER), Cardiac MRI without contrast (OTHER), Blood Test (OTHER), Pulmonary Function Test (OTHER).
Who is sponsoring clinical trial NCT02834650?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.